HOME >> MEDICINE >> NEWS
Statins protect from death from pneumonia

Patients hospitalised because of pneumonia are at less risk of dying from the disease if they have been taking the widely used cholesterol-lowering drugs 'statins' before hospital admission. These results, published today in the Open Access journal Respiratory Research, suggest another beneficial use of statins, which are prescribed to an increasing number of patients to prevent and treat high cholesterol, diabetes, heart disease and vascular disease.

Pneumonia is the seventh most common cause of death and the leading cause of death from infection in the USA, where it kills up to 40,000 people every year those most at risk are very young children, elderly people and patients with underlying health problems such as AIDS or chronic obstructive pulmonary disease (CPOD). The disease is caused by viruses or bacteria, which are becoming resistant to the antibiotics used to treat bacterial pneumonia.

Eric Mortensen and colleagues, from the University of Texas Health Centre at San Antonio measured the risk of dying from pneumonia in patients admitted with pneumonia who were taking statins prior to their entry into hospital. They compared it with the risk of dying from the disease in pneumonia patients who were not taking statins. The authors used the Pneumonia Severity Index to rate the risk of dying within 30 days of admission to hospital in the two groups of patients. The results of their statistical analysis show that patients who were on a statin when they entered hospital were 2.8 times less likely to die than patients who were not on statins.

"Prior outpatient statin use was associated with decreased mortality in patients hospitalized with community-acquired pneumonia despite their use being associated with comorbid illnesses likely to contribute to increased mortality", write the authors.

More research is needed to explain the protective effect of statins on patients suffering from pneumonia. Statins act on the cholesterol-regula
'"/>

Contact: Juliette Savin
juliette.savin@biomedcentral.com
44-207-631-9931
BioMed Central
24-Jul-2005


Page: 1 2

Related medicine news :

1. Statins linked to lower risk of infection
2. Statins protect smokers from lung damage
3. Statins reduce risk of stroke in heart patients
4. Statins prove life-saving in patients with acute coronary syndromes
5. Statins may improve circulation in the retina
6. Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study
7. Statins have neutral effect on risk of cancer
8. Statins may simulate stem cells for heart repair
9. Statins reduce the risk of stroke and death after carotid artery surgery
10. Statins use associated with lower risk of fractures
11. Statins not associated with reduced dementia risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Statins protect from death from pneumonia

(Date:5/28/2015)... The MIT Sloan Center for Information Systems Research ... of the MIT CISR research team interviewed members of ... case study about Healthcare IQ’s business model within the ... ‘Healthcare IQ: Competing as the “Switzerland” of Health Spend ... hospital financial software provider through its evolution to becoming ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 Orem, UT—Dymicron, ... in-human surgeries using their unique Triadyme-C cervical total disc ... surgeon Dr. William D. Smith at the American Institute ... “The patients are responding well to the implantation of ... of AIMIS Spine Center and Chief of Neurosurgery for ...
(Date:5/28/2015)... Aureus Medical Group (web: aureuslocumtenens.com), a national leader ... that it will participate as an exhibitor at the ... be held June 9-14, 2015 in New Orleans, Louisiana. ... and exhibits with products and services. , Representatives ... be available to speak with attendees about its full ...
(Date:5/28/2015)... York, NY (PRWEB) May 28, 2015 Peggy ... elected Chief Delegate to the American Physical Therapy Association House ... by the Delegation at their Delegate Assembly. This will ... House of Delegates serves as coordinator and principle spokesperson for ... Delegates. The Board of Directors or Delegate Assembly may direct ...
(Date:5/27/2015)... and volume loss in the skin have met its ... is excited to introduce a custom menu of non-invasive ... surgical intervention, and without downtime. , “We now use ... that can lift skin using focused ultrasound, and combine ... lifting formula than its predecessor Radiesse, to visibly and ...
Breaking Medicine News(10 mins):Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:Healthcare Staffing Leader, Aureus Medical Group, to Exhibit at the American Association of Nurse Practitioners’ 2015 National Conference 2Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2
(Date:5/28/2015)...  Array BioPharma Inc. (NASDAQ: ARRY ) today ... AstraZeneca) at the 2015 American Society of Clinical Oncology ... – June 2, 2015 in Chicago ... a total of 6 pivotal trials, with top-line results ... in NRAS mutant melanoma patients) and SUMIT (selumetinib with ...
(Date:5/28/2015)... , May 28, 2015 The ... North America , Europe ... world (RoW). The global departmental PACS market is expected to ... between 2014 and 2019. Browse through the TOC ... the industry trends and segments, with help of various tables ...
(Date:5/28/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ... "2015 Strategies in the US Ancillary Hospital Locations ... to their offering. This new 973-page ... of the diagnostic testing markets outside the main ... includes analysis of the market dynamics, size, growth, ...
Breaking Medicine Technology:Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 2Departmental PACS Market is Expected to Reach $3,807.4 Billion by 2019, at a CAGR of 10.0% From 2014 to 2019 3Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2
Cached News: